News

February 23, 2018

Last Week's Webinar on Treatment Access and Clinical Trials Now Available

A recording of last week’s webinar updating the community on treatment access and clinical trials is now available online. A PDF of the webinar presentation is also available for download.

An update on...

READ MORE   |  

Topics: Community & Awareness, Support & Care, Front Page News

February 22, 2018

Cure SMA Receives Generous Gift from the Weisman Family Foundations

Cure SMA Receives Generous Gift from the Weisman Family Foundations

The Weisman Family Foundations recently awarded $65,800 to Cure SMA, in order to further new scientific research, and to help provide access to treatments, clinical trials and care.

Each year, a generous donation is made by the Weisman Family Foundations. Through contributions from...

READ MORE   |  

Topics: Community & Awareness, Front Page News

February 21, 2018

Phase 2 Clinical Trial Results for CK-2127107 Expected in Second Quarter of 2018

Phase 2 Clinical Trial Results for CK-2127107 Expected in Second Quarter of 2018

Cytokinetics is currently conducting a Phase 2 clinical trial of CK-2127107 – now referred to by the generic name, reldesemtiv – which is designed to assess the investigational agent’s effect on multiple measures of muscle function in both ambulatory and non-ambulatory...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

Items 1 - 3 of 437  12345678910Next

© 2018 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software